Current perspectives of the roles of the central norepinephrine system in anxiety and depression
AW Goddard, SG Ball, J Martinez… - Depression and …, 2010 - Wiley Online Library
Norepinephrine (NE) is a major monoamine neurotransmitter that has widespread effects
across multiple brain areas to regulate arousal and stress responses. The underlying …
across multiple brain areas to regulate arousal and stress responses. The underlying …
Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: A quantitative review
SG Ball, L Baer, MW Otto - Behaviour Research and Therapy, 1996 - Elsevier
Recent reviews and meta-analytic studies have provided an encouraging account of the
effectiveness of behavioral interventions for obsessive-compulsive disorder (OCD). One …
effectiveness of behavioral interventions for obsessive-compulsive disorder (OCD). One …
Clinical relevance of fatigue as a residual symptom in major depressive disorder
Residual symptoms of major depressive disorder (MDD) following treatment are increasingly
recognized as having a negative impact on the patient because of their association with lack …
recognized as having a negative impact on the patient because of their association with lack …
[HTML][HTML] Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis
KB Gordon, A Blauvelt, KA Papp… - … England Journal of …, 2016 - Mass Medical Soc
Background Two phase 3 trials (UNCOVER-2 and UNCOVER-3) showed that at 12 weeks of
treatment, ixekizumab, a monoclonal antibody against interleukin-17A, was superior to …
treatment, ixekizumab, a monoclonal antibody against interleukin-17A, was superior to …
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
CEM Griffiths, K Reich, M Lebwohl, P Van De Kerkhof… - The Lancet, 2015 - thelancet.com
Background Ixekizumab is a humanised monoclonal antibody against the proinflammatory
cytokine interleukin 17A. We report two studies of ixekizumab compared with placebo or …
cytokine interleukin 17A. We report two studies of ixekizumab compared with placebo or …
Self-care in medical education: effectiveness of health-habits interventions for first-year medical students
S Ball, A Bax - Academic Medicine, 2002 - journals.lww.com
Purpose To examine changes in health habits (sleep, alcohol, and exercise) and the effects
of an educational intervention promoting self-care on the emotional and academic …
of an educational intervention promoting self-care on the emotional and academic …
HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits
W Xu, PA Santini, JS Sullivan, B He, M Shan… - Nature …, 2009 - nature.com
Contact-dependent communication between immune cells generates protection but also
facilitates viral spread. Here we found that macrophages formed long-range actin-propelled …
facilitates viral spread. Here we found that macrophages formed long-range actin-propelled …
Effectiveness and cost-effectiveness of universal school-based mindfulness training compared with normal school provision in reducing risk of mental health problems …
Background Systematic reviews suggest school-based mindfulness training (SBMT) shows
promise in promoting student mental health. Objective The My Resilience in Adolescence …
promise in promoting student mental health. Objective The My Resilience in Adolescence …
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial
J Hartford, S Kornstein, M Liebowitz… - International Clinical …, 2007 - journals.lww.com
This study examined the efficacy and tolerability of duloxetine 60–120 mg/day for the
treatment of patients with generalized anxiety disorder. This was a multicenter, randomized …
treatment of patients with generalized anxiety disorder. This was a multicenter, randomized …
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
J Zajicek, S Ball, D Wright, J Vickery, A Nunn… - The Lancet …, 2013 - thelancet.com
Background Laboratory evidence has shown that cannabinoids might have a
neuroprotective action. We investigated whether oral dronabinol (Δ 9-tetrahydrocannabinol) …
neuroprotective action. We investigated whether oral dronabinol (Δ 9-tetrahydrocannabinol) …